ALKEM LABORATORIES LIMITED

Scale -

Ebitda is 3589 Rs Cr; Annual Growth is 19 %; Continuous Growth over 3 years; 5 Year CAGR is 13 %
Revenue is 14712 Rs Cr; Continuous Growth over 3 years; in Top Quartile
PAT is 2353 Rs Cr; Continuous Growth over 3 years; in Top Quartile
PBT is 772 Rs Cr; in Top Quartile; 5 Year CAGR is 12 %
Quarterly Profit is 521 Rs Cr; in Top Quartile

Profitability -

PBDIT Margin is 24.39 %; Continuous Growth over 3 years

Return -

Asset Turnover is 76 %; Continuous Decline over 3 years

Efficiency -

Inventory Turnover Ratio is 4.7; Continuous Growth over 3 years; 5 Year CAGR is 37 %

Solvancy -

Debt/Equity is 0.12; 5 Year CAGR is -20 %; Annual Growth is 33 %

Long term Debt is 492 Rs Cr; Annual Growth is 58 %; Continuous Growth over 3 years; 5 Year CAGR is 169 %
Total Debt is 1624 Rs Cr; Annual Growth is 53 %
Contingent Liabilities is 1388 Rs Cr; Annual Growth is 40 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 34 %

Quality -

Operating cashflow/ebitda is 55 %; Continuous Decline over 3 years
Operating cashflow/PAT is 83 %; Continuous Decline over 3 years
Current Tax/PAT is 26 %; Continuous Growth over 3 years

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: